Search

Your search keyword '"Ackens, A."' showing total 124 results

Search Constraints

Start Over You searched for: Author "Ackens, A." Remove constraint Author: "Ackens, A."
124 results on '"Ackens, A."'

Search Results

1. Trends in mortality in people with HIV from 1999 to 2020: a multi-cohort collaboration

2. External validation of the PAGE-B score for HCC risk prediction in people living with HIV/HBV coinfection

3. Application of PROFINET IO in Neutron Scattering Instruments

4. Hepatitis C Elimination in the Netherlands (CELINE): How nationwide retrieval of lost to follow-up hepatitis C patients contributes to micro-elimination

5. Mpox vaccination willingness, determinants, and communication needs in gay, bisexual, and other men who have sex with men, in the context of limited vaccine availability in the Netherlands (Dutch Mpox-survey)

6. Real-world effectiveness and tolerability of switching to doravirine-based antiretroviral therapy in people with HIV: a nationwide, matched, prospective cohort study

7. HCV micro-elimination in individuals with HIV in the Netherlands 4 years after universal access to direct-acting antivirals: a retrospective cohort study

8. Cascade of care among hepatitis B patients in Maastricht, the Netherlands, 1996 to 2018

9. Pilot implementation of a home-care programme with chlamydia, gonorrhoea, hepatitis B, and syphilis self-sampling in HIV-positive men who have sex with men

12. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy

13. External validation of the PAGE-B score for HCC risk prediction in people living with HIV/HBV coinfection

14. Low hepatitis C virus-viremia prevalence yet continued barriers to direct-acting antiviral treatment in people living with HIV in the Netherlands

15. Mpox vaccination willingness, determinants, and communication needs in gay, bisexual, and other men who have sex with men, in the context of limited vaccine availability in the Netherlands (Dutch Mpox-survey)

16. Monkeypox vaccination willingness, determinants, and communication needs in gay, bisexual, and other men who have sex with men, in the context of limited vaccine availability in the Netherlands (Dutch MPX-survey)

17. Monkeypox vaccination willingness, determinants, and communication needs in gay, bisexual, and other men who have sex with men, in the context of limited vaccine availability in the Netherlands (Dutch MPX-survey)

18. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy: A multinational prospective cohort study

19. Management of drug interactions with direct‐acting antivirals in Dutch HIV/hepatitis C virus‐coinfected patients: adequate but not perfect

20. Hepatitis C Elimination in the Netherlands (CELINE): How nationwide retrieval of lost to follow-up hepatitis C patients contributes to micro-elimination

21. Hepatitis C Elimination in the Netherlands (CELINE): How nationwide retrieval of lost to follow-up hepatitis C patients contributes to micro-elimination

23. Human immunodeficiency virus continuum of care in 11 european union countries at the end of 2016 overall and by key population: Have we made progress?

24. Human Immunodeficiency Virus Continuum of Care in 11 European Union Countries at the End of 2016 Overall and by Key Population: Have We Made Progress?

25. Low hepatitis C virus-viremia prevalence yet continued barriers to direct-acting antiviral treatment in people living with HIV in the Netherlands

26. A highly virulent variant of HIV-1 circulating in the Netherlands

27. Mpox vaccination willingness, determinants, and communication needs in gay, bisexual, and other men who have sex with men, in the context of limited vaccine availability in the Netherlands (Dutch Mpox-survey)

29. Gender differences in the use of cardiovascular interventions in HIV‐positive persons; the D:A:D Study

30. Reaching HCV micro-elimination in HIV/HCV co-infected individuals in the Netherlands: exploring remaining barriers to HCV treatment

31. HCV micro-elimination in individuals with HIV in the Netherlands 4 years after universal access to direct-acting antivirals

32. Pilot implementation of a home-care programme with chlamydia, gonorrhoea, hepatitis B, and syphilis self-sampling in HIV-positive men who have sex with men

33. Performance issues of the new DAQ system for WASA at COSY

35. The new DAQ system for WASA at COSY

36. HCV micro-elimination in individuals with HIV in the Netherlands 4 years after universal access to direct-acting antivirals: a retrospective cohort study

37. P030 Pilot implementation of a home-care program for chlamydia, gonorrhoea and syphilis testing in HIV positive MSM

38. Progression of liver fibrosis following acute hepatitis C virus infection in HIV-positive MSM

39. Predictive Performance of Cardiovascular Disease Risk Prediction Algorithms in People Living With HIV

41. Itching dermatitis on the leg of a 46-year-old HIV-positive man from Jamaica

44. High treatment uptake in human immunodeficiency virus/ hepatitis C virus-coinfected patients after unrestricted access to direct-acting antivirals in the Netherlands

45. Treatment of chronic hepatitis C with direct acting antiviral agents in patients with haemophilia, end-stage liver disease and coinfected with HIV

47. Concentrator for the readout of the PANDA Micro Vertex Detector based on MicroTCA

48. Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study

49. Performance Issues of the New DAQ System for WASA at COSY

50. Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study

Catalog

Books, media, physical & digital resources